Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies
Author(s) -
Xinjie Li,
Yue Yin,
Ling Pang,
Shuyun Xu,
Fengmin Lu,
Dong Xu,
Tao Shen
Publication year - 2021
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2021.05.080
Subject(s) - medicine , antibody , covid-19 , immunoassay , gold standard (test) , virology , chemiluminescence , chemiluminescent immunoassay , immunology , chromatography , chemistry , infectious disease (medical specialty) , disease , outbreak
A large number of COVID-19 patients are in recovery, and millions of people are vaccinated for COVID-19 globally. This calls for a rapid screening strategy of SARS-CoV-2 protective antibodies, generated in rehabilitated and vaccinated populations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom